QHM-2025-9899 Farah Chemists Limited

The procurement process initiated by NHS North East and North Cumbria Integrated Care Board encompasses the contract titled "QHM-2025-9899 Farah Chemists Limited," catering to the health services industry. The primary focus is on stocking palliative drugs under the Direct Award Process A, as per the Health Care Services (Provider Selection Regime) regulations 2023. This contract, valued nominally at £0.01 as services are activity-based, runs from 1st April 2025 to 31st March 2026, although the services commenced under an implied contract.

The procurement falls within the UKC region, specifically around Sunderland and Burnopfield. The process followed a limited procurement method, with no prior publication of a call for competition, and has reached the award stage as of 14th October 2025. This contract represents a strategic opportunity for businesses in the health services sector, particularly those specializing in pharmaceutical supplies.

Farah Chemists Limited, already a large-scale supplier, has been awarded the contract, highlighting the potential for other large or well-established firms in the pharmaceutical industry to explore similar opportunities. The absence of a competitive bidding process implies that businesses with unique capabilities or those able to deliver specialised health services would find such opportunities advantageous for growth. Engaging with the NHS North East and North Cumbria Integrated Care Board can pave the way for future engagements and collaborations in the healthcare domain.